CORD-19:0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e / 22493-22759 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e","sourcedb":"CORD-19","sourceid":"0329e0f2e3b8ab0eabe2afe0e5214cc88c61080e","text":"Favipiravir treatment reduced the mortality rate in the low viral load group to 33% compared with the historical control group that was not treated with favipiravir, but this reduction in the mortality rate was not statistically significant (Sissoko, et al., 2016) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T123","span":{"begin":0,"end":266},"obj":"Sentence"},{"id":"T84037","span":{"begin":0,"end":266},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T123","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T84037","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T123","span":{"begin":0,"end":266},"obj":"Sentence"}],"attributes":[{"subj":"T123","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T208","span":{"begin":132,"end":135},"obj":"Disease"},{"id":"T209","span":{"begin":207,"end":210},"obj":"Disease"}],"attributes":[{"id":"A208","pred":"mondo_id","subj":"T208","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A209","pred":"mondo_id","subj":"T209","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T208","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T209","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#e1ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#dd93ec"},{"id":"CORD-19-PD-MONDO","color":"#93ecc3"}]}]}}